Table 4.

Patients with spasticity: physiotherapy and muscle-relaxing drug therapy before stroke and after diagnosis of spasticity

Therapy	Period of therapy,
	Six month before stroke n = 126		Six month after onset of spasticity (observation period 2)
	n	% (95% CI)	Survivors n = 92		Deaths n = 34
			n	% (95% CI)	n	% (95% CI)
Physiotherapy
Inpatient	10	7.9 (3.9–14.1)	82	89.1 (80.9–94.7)	30	88.2 (72.6–96.7)
Outpatient	14	11.1 (6.2–17.9)	44	47.8 (37.3–58.5)	3	8.8 (1.9–23.7)
Total physiotherapy	21	16.7 (10.6–24.3)	89	96.7 (90.8–99.3)	30	88.2 (72.6–96.7)
Oral drug therapy
Baclofen	1	0.8 (0.02–4.3)	9	9.8 (4.6–17.8)	1	2.9 (0.1–15.3)
Tizanidine	0	–	1	1.1 (0.03–5.1)	0	–
Others	4	3.2 (0.9–7.6)	4	4.3 (1.2–10.8)	1	2.9 (0.1–15.3)
Total	5	4.0 (1.3–9.0)	12	13.0 (6.9–21.7)	2	5.9 (0.7–19.7)
Baclofen intrathecal	0	–	0	–	0	–
Botulinum toxin injection	0	–	0	–	0	–

Abbreviation: CI, confidence interval.